Noha E. Farag
Impact in
-
- Curcumin's Biomedical Applications
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
-
- Ion channel regulation and function 2
- TGF-β signaling in diseases 1
- Metabolism, Diabetes, and Cancer 1
-
- Cardiac electrophysiology and arrhythmias 2
- Co-authors
- Sawsan A. Zaitone (10 shared papers)Shymaa E. Bilasy (3 shared papers)Manal S. Fawzy (3 shared papers)Dina M. Khodeer (2 shared papers)Yasser M. Moustafa (2 shared papers)Lamiaa N. Hammad (1 shared paper)Eman Z. Abdelaziz (1 shared paper)Bassant M. Barakat (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (2 papers)Canadian Journal of Physiology and Pharmacology (2 papers)Pharmacological Reports (1 paper)Nanomaterials (1 paper)
- Partner nations
- EgyptSaudi ArabiaUnited Arab Emirates
In The Last Decade
Noha E. Farag
14 papers receiving 293 citations
Peers
Comparison fields: 5 of 77
- Molecular Medicine 23
- Cardiology and Cardiovascular Medicine 64
- Biological Psychiatry 7
- Pharmacology 43
- Endocrinology, Diabetes and Metabolism 42
Countries citing papers authored by Noha E. Farag
This map shows the geographic impact of Noha E. Farag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noha E. Farag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noha E. Farag more than expected).
Fields of papers citing papers by Noha E. Farag
This network shows the impact of papers produced by Noha E. Farag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noha E. Farag. The network helps show where Noha E. Farag may publish in the future.
Co-authors
The 25 scholars most cited alongside Noha E. Farag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 67 | |
| 2 | 2015 | 47 | |
| 3 | 2013 | 30 | |
| 4 | 2015 | 30 | |
| 5 | 2022 | 23 | |
| 6 | 2023 | 20 | |
| 7 | 2019 | 18 | |
| 8 | 2022 | 16 | |
| 9 | 2017 | 16 | |
| 10 | 2020 | 13 | |
| 11 | 2021 | 7 | |
| 12 | 2020 | 5 | |
| 13 | 2025 | 2 | |
| 14 | 2015 | 1 |
About Noha E. Farag
Noha E. Farag is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Pharmacology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 14 papers that have together received 295 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Ion channel regulation and function (2 papers), Pharmacological Effects of Medicinal Plants (1 paper), Cancer Treatment and Pharmacology (1 paper), Nanoplatforms for cancer theranostics (1 paper), TGF-β signaling in diseases (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Molecular Medicine (23 citations), Cardiology and Cardiovascular Medicine (64 citations), Biological Psychiatry (7 citations), Pharmacology (43 citations) and Endocrinology, Diabetes and Metabolism (42 citations). Noha E. Farag has collaborated with scholars based in Egypt, Saudi Arabia and United Arab Emirates. Frequent co-authors include Sawsan A. Zaitone, Shymaa E. Bilasy, Manal S. Fawzy, Dina M. Khodeer, Yasser M. Moustafa, Lamiaa N. Hammad, Eman Z. Abdelaziz, Bassant M. Barakat, Mohamed Ahmed Eladl and Nagla A. El-Sherbeeny. Their work appears in journals such as Biomedicine & Pharmacotherapy, Naunyn-Schmiedeberg s Archives of Pharmacology, Canadian Journal of Physiology and Pharmacology, Pharmacological Reports and Nanomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.